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Runx  family  transcription  factors  consist  of Runx1,  Runx2,  and  Runx3.  Runx1  is involved  in chondro-
cyte  differentiation  at an  early  stage.  Runx2  is  a  major  transcription  factor  for chondrocyte  maturation,
and  Runx3  has  a redundant  function  with  Runx2  and  it is  partly  involved  in  chondrocyte  maturation.
Runx2  directly  regulates  Ihh  expression  and  enhances  chondrocyte  proliferation.  Runx2  is  an  essential
transcription  factor  for  osteoblast  differentiation.  Heterozygous  mutation  of  RUNX2  causes  cleidocranial
dysplasia,  which  is characterized  by  hypoplastic  clavicles,  open  fontanelles,  and  supernumerary  teeth.
Runx2  directly  regulates  Sp7 expression,  and  Runx2  together  with  Sp7  and canonical  Wnt  signaling  com-
pletes  determination  of the  lineage  of  mesenchymal  cells  into  osteoblasts.  Runx2  expression  in  osteoblasts
is  regulated  by a  343-bp  enhancer.  Dlx5/6  and  Mef2  directly  bind  this  enhancer;  form  an  enhanceosome
with  Tcf7,  -catenin,  Sox5/6,  Smad1,  and  Sp7;  and  activate  this  enhancer.  Msx2  inhibits  this  enhancer,
and  switching  of  the  binding  of Msx2  to Dlx5  is  important  for this  activation.  Core  binding  factor    (Cbfb)
forms  a heterodimer  with  Runx  family  proteins  and  enhances  their  DNA-binding  capacity.  In  Cbfb  con-
ditional  knockout  mice  in osteoblast  and  chondrocyte  lineages,  the  differentiation  of  chondrocytes  and
osteoblasts  is inhibited.  All  of the Runx  family  proteins  are  reduced  in  the  cartilaginous  limb  skeletons
and  calvariae  in  Cbfb  conditional  knockout  mice,  although  the reduction  of Runx2  protein  in calvariae  is
much  milder  than that  in cartilaginous  limb  skeletons.  Therefore,  Cbfb  regulates  skeletal  development
by  stabilizing  Runx  family  proteins,  and  Runx2  protein  stability  is less  dependent  on  Cbfb  in  calvariae
than  in  cartilaginous  limb  skeletons.
©  2014  Japanese  Stomatological  Society.  Published  by Elsevier  Ltd.  All  rights  reserved.ontents
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. Introduction
The vertebrate skeleton is composed of cartilage and bone.
then replaced with bone by osteoblasts and osteoclasts through
the process of endochondral ossiﬁcation. After mesenchymal
cell condensation, pluripotent mesenchymal cells differentiateone is formed through either intramembranous or endochondral
ssiﬁcation. Osteoblasts directly form intramembranous bones,
hile chondrocytes ﬁrst form a cartilaginous skeleton, which is
∗ Tel.: +81 95 819 7630; fax: +81 95 819 7633.
E-mail  address: komorit@nagasaki-u.ac.jp
ttp://dx.doi.org/10.1016/S1348-8643(14)00032-9
348-8643/© 2014 Japanese Stomatological Society. Published by Elsevier Ltd. All rights rinto immature chondrocytes, which produce Col2a1 and proteo-
glycan. The immature chondrocytes mature into hypertrophic
chondrocytes, which express Col10a1, and ﬁnally become ter-
minal hypertrophic chondrocytes, which express Spp1 (secreted
phosphoprotein 1/osteopontin), Ibsp (integrin-binding sialopro-
tein/bone sialoprotein II), Mmp13 (matrix metallopeptidase 13),
and Vegf (vascular endothelial growth factor) [1–3].
eserved.
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Fig. 2. Regulation of osteoblast differentiation by Runx2, Tcf/Lef, Ctnnb1, and Sp7.
Runx2, Tcf/Lef, Ctnnb1, and Sp7 are required for the differentiation of pluripotent
mesenchymal  cells to osteoblasts. Osteoblast-speciﬁc expression of Runx2 is reg-
ulated by Dlx5/6, Mef2, Tcf7, Ctnnb1, Smad1/5, Sp7, and Sox5/6, which activate T. Komori / Oral Science
Runx family transcription factors consist of Runx1, Runx2, and
unx3. Runx2 is an essential transcription factor for osteoblast
ifferentiation [4,5]. Heterozygous mutation of RUNX2 causes clei-
ocranial dysplasia (CCD), which is characterized by hypoplastic
lavicles, open fontanelles, and supernumerary teeth, and Runx2+/−
ice also show hypoplastic clavicles and open fontanelles [6]. Fur-
hermore, Runx2 regulates chondrocyte maturation and Runx3 is
artly involved in it [2,7–12]. Runx2 is also required for vascular
nvasion into the mineralized cartilage, which is composed of ter-
inal hypertrophic chondrocytes [13,14]. Runx1 is also involved in
hondrocyte differentiation, at least in the development of some of
he endochondral bones [15,16]. Core binding factor  (Cbfb) is a
o-transcription factor, which forms a heterodimer with Runx fam-
ly transcription factors [17]. In this review, the major functions
f Runx2 in osteoblasts and chondrocytes, the functions of Cbfb
n skeletal development, and involvement of Runx1 and Runx3 in
ndochondral ossiﬁcation are described.
. Runx2 and chondrocyte differentiation
Runx2 is weakly expressed in resting and proliferating chon-
rocytes and upregulated in prehypertrophic chondrocytes, and
he high expression is maintained in hypertrophic and terminal
ypertrophic chondrocytes [2]. Runx2−/− mice die at birth due to
he failure of breathing caused by the lack of ossiﬁcation in the
horacic cage. In the skeleton of Runx2−/− newborn mice, all endo-
hondral bones are cartilaginous, and mineralization is virtually
bsent throughout the skeleton, except the tibia, ﬁbula, radius,
nd ulna [4]. When the chondrocytes terminally differentiate, the
atrix in the terminal hypertrophic chondrocyte layer is miner-
lized. In the tibia, ﬁbula, radius, and ulna in Runx2−/− embryos
t embryonic day (E) 18.5, chondrocytes terminally differentiate
nd express Spp1, Ibsp, and Mmp13, and the matrix is mineralized
ithout vascular invasion. However, chondrocyte hypertrophy and
ol10a1 expression are virtually absent in the rest of the skeleton.
urthermore, the expression of Ihh and Pth1r is severely reduced
2]. These ﬁndings indicate that Runx2 is required for chondrocyte
ig. 1. Regulation of chondrocyte maturation and proliferation by Runx2 and
unx3.  Runx2 enhances chondrocyte maturation and Runx3 is partly involved it.
unx2 induces the expression of Ihh, which enhances chondrocyte proliferation.
hh  induces the expression of Pthlh, which inhibits Runx2 expression. Further, Ihh
s required for the expression of Runx2 in mesenchymal cells in the perichondrium,
n  which bone collar formation occurs.the 343-bp osteoblast-speciﬁc enhancer. Runx2 regulates Sp7 and Tcf7 expression.
Therefore,  there are reciprocal regulations between Runx2 and Sp7 and between
Runx2  and Tcf7 [29].
maturation and vascular invasion into the cartilage (Fig. 1). How-
ever, these ﬁndings also indicate that some transcription factors
have a redundant function with Runx2 in chondrocyte maturation.
Runx3 is also expressed in prehypertrophic and hypertrophic
chondrocytes. Chondrocyte maturation is mildly retarded in
Runx3−/− mice at E15.5 but not at E18.5. Hypertrophic chondro-
cytes are completely absent, and the expression of Ihh and Pth1r
is undetectable in the whole skeleton in Runx2−/−Runx3−/− mice,
indicating that chondrocyte maturation is completely blocked in
Runx2−/−Runx3−/− mice [11]. Therefore, Runx2 is a major transcrip-
tion factor for chondrocyte maturation and Runx3 has a redundant
function with Runx2 in chondrocyte maturation (Fig. 1).
The  lengths of limbs are shortened in Runx2−/− mice and fur-
ther shortened in Runx2−/−Runx3−/− mice [11]. As chondrocyte
proliferation  is reduced in Ihh−/− mice, Ihh positively regu-
lates chondrocyte proliferation [18]. Ihh expression is severely
reduced in Runx2−/− mice. There are several perfect Runx2-binding
sequences in the Ihh promoter, and Runx2 directly regulates Ihh
expression (Fig. 1). Although Ihh expression is undetectable in
Runx2−/−Runx3−/− mice, Runx3 cannot regulate Ihh expression. The
further reduction of limb length in Runx2−/−Runx3−/− mice com-
pared with that in Runx2−/− mice is due to the reduction in the size
of chondrocytes because chondrocyte maturation is completely
blocked in Runx2−/−Runx3−/− mice [11].
3. Runx2 and osteoblast differentiation
Intramembranous bones and bone collar formation are com-
pletely absent in Runx2−/− mice. Osteoblast differentiation is
blocked at an early stage, and weak alkaline phosphatase activ-
ity is detected only in the periphery of the calciﬁed cartilage in the
tibia, ﬁbula, radius, and ulna [4]. Furthermore, Runx2−/− calvarial
cells spontaneously differentiate into adipocytes and differentiate
into chondrocytes in the presence of bone morphogenetic pro-
tein (BMP)-2 in vitro, but they do not differentiate into osteoblasts
even in the presence of BMP-2 in vitro or in vivo [19]. Therefore,
Runx2−/− mesenchymal cells have the potential to differentiate into
adipocytes and chondrocytes, but they completely lack the poten-
tial to differentiate into osteoblasts (Fig. 2).
Osteoblast differentiation is also completely blocked in Sp7−/−mice and mice with the deletion of Ctnnb1 (-catenin) in mes-
enchymal cells (Fig. 2). In both types of mice, perichondral
mesenchymal cells, which express Runx2, condense and differen-
tiate into chondrocytes, indicating that Sp7−/− mesenchymal cells
T. Komori / Oral Science Intern
Fig. 3. The functions of Runx family transcription factors and Cbfb in skeletal devel-
opment. Runx1 and Runx2 have a redundant function in chondrocyte differentiation,
at  least in some parts of the skeleton. Runx2 is a major transcription factor for
chondrocyte  maturation, and Runx3 is partly involved in it. Runx2 is an essential
transcription  factor for osteoblast differentiation, and the 343-bp enhancer regulates
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ﬂ/ﬂunx2 expression in osteoblasts. The contribution of Runx1 and Runx3 in osteoblast
ifferentiation  remains to be clariﬁed. Cbfb forms heterodimers with Runx family
ranscription factors, enhances their DNA binding, and inhibits their degradation.
nd Ctnnb1−/− mesenchymal cells maintain the potential to dif-
erentiate into chondrocytes [20–23]. However, the mesenchymal
ondensation and the differentiation of the mesenchymal cells into
hondrocytes are not observed in Runx2−/− mice [4]. As Sox9 is
ssential for mesenchymal condensation and chondrocyte differ-
ntiation during embryogenesis [24], these ﬁndings suggest that
unx2 is required for mesenchymal condensation, which is a pre-
equisite for chondrocyte differentiation, in the cells that do not
xpress enough Sox9.
Runx2  directly regulates Sp7 expression [25,26]. It also inhibits
dipocyte differentiation and directs the mesenchymal cells to
steoblasts. Runx2 together with Sp7 and canonical Wnt  signal-
ng completes the lineage determination of mesenchymal cells into
steoblasts, completely blocking the ability of mesenchymal cells
o differentiate into chondrocytes [27] (Fig. 2).
.  Transcriptional regulation of Runx2 gene for osteoblast
ifferentiation
Runx2  messenger RNA (mRNA) is transcribed from two  pro-
oters, distal (P1) and proximal (P2) promoters, and speciﬁcally
xpressed in osteoblasts and chondrocytes [28]. Runx2 expression
n osteoblasts is mainly transcribed from the P1 promoter. How-
ver, neither promoter drives reporter genes to osteoblasts in mice,
uggesting the presence of an enhancer for the osteoblast-speciﬁc
xpression. Green ﬂuorescent protein (GFP) reporter mice using a
acterial artiﬁcial chromosome (BAC) clone of the Runx2 gene locus
uccessfully recapitulated the endogenous expression of Runx2.
n enhancer for osteoblast-speciﬁc expression has been identi-
ed by deletion of the BAC clone. GFP is speciﬁcally expressed in
steoblasts in GFP reporter mice driven by the 343-bp enhancer
nd a minimal promoter (Fig. 3). The sequence of this enhancer is
ighly conserved among mouse, human, dog, horse, opossum, and
hicken. Dlx5/6 and Mef2 directly bind to the enhancer. Dlx5/6 and
ef2 form an enhanceosome with Tcf7, Ctnnb1, Sox5/6, Smad1, and
p7, and they activate the enhancer (Fig. 2). Although both Msx2
nd Dlx5 bind to the homeobox motif in the enhancer, Msx2 inhibits
he enhancer activity. The binding of Msx2 to the enhancer is
etected in uncommitted mesenchymal cells, C3H10T1/2, whereas
he binding of Dlx5 to the enhancer is detected in osteoblastic
C3T3-E1 cells. Therefore, the switching of the binding from Msx2o Dlx5 is important for activation of the enhancer [29].
The  enhancer is highly enriched for histone H3 mono- and
imethylated at Lys4 and acetylated at Lys27 and Lys18, but
t is depleted for histone H3 trimethylated at Lys4 in primaryational 12 (2015) 1–4 3
osteoblasts. Furthermore, the histone variant H2A.Z is enriched
in the enhancer. These are typical chromatin modiﬁcations in
enhancers. The enhancer is sufﬁcient to direct Runx2 expression
speciﬁcally to osteoblasts [29].
5. Cbfb and Runx family transcription factors
Inversion of chromosome 16 involves breakage of CBFB, and it
is associated with acute myeloid leukemia in humans. Cbfb forms
a heterodimer with Runx1, and both Runx1 and Cbfb are essential
for hematopoiesis in the fetal liver [30]. Cbfb−/− mice die at midges-
tation due to the absence of fetal liver hematopoiesis. Rescue of
hematopoiesis in Cbfb−/− mice by mating with Cbfb transgenic
mice under the control of Gata1 promoter, which directs reporter
gene expression to primitive and deﬁnitive erythroid cells, revealed
the requirement for Cbfb in skeletal development [31]. Rescue of
hematopoiesis in Cbfb−/− mice using Tek promoter Cbfb transgenic
mice also showed similar results [32]. In another mouse model in
which GFP was inserted into exon 5 of Cbfb to generate a Cbfb–GFP
fusion protein, the skeletal development was  also impaired [33].
Chondrocyte maturation is delayed, chondrocyte proliferation
is reduced, and osteoblast differentiation is inhibited in Cbfb condi-
tional knockout mice using Dermo1-Cre knock-in mice, in which Cre
recombinase is expressed in mesenchymal cells giving rise to both
chondrocyte and osteoblast lineages [34]. The proteins of Runx1,
Runx2, and Runx3 are reduced in the cartilaginous limb skeletons of
Cbfb conditional knockout embryos at E15.5. The proteins of Runx1,
Runx2, and Runx3 are also reduced in calvarial tissues of Cbfb con-
ditional knockout embryos, although the reduction of the Runx2
protein in calvarial tissues is much milder than that in cartilagi-
nous limb skeletons [34] (Fig. 3). Therefore, the Runx2 protein is
more stable in calvariae than cartilaginous limb skeletons in the
absence of Cbfb. This suggests that some unknown proteins com-
pensate for the lack of Cbfb in the calvariae to protect against the
degradation of the Runx2 protein. Although the development of
endochondral bones is virtually normal in Runx2+/− mice, the cal-
variae and clavicles are more severely affected in Runx2+/− mice
than in Cbfb conditional knockout mice [34]. The relative stability
of the Runx2 protein in the calvariae of Cbfb conditional knock-
out mice can explain why  Cbfb conditional knockout mice show a
severe delay in endochondral ossiﬁcation but milder deformities
in the calvariae and the lateral parts of clavicles, which are formed
through intramembranous ossiﬁcation. All Runx family proteins are
involved in endochondral ossiﬁcation, and Cbfb is likely to be nec-
essary for all of the Runx family proteins in endochondral bone
formation (Fig. 3). In particular, Runx2 and Runx3 have redundant
function in chondrocyte maturation, and Runx3 partly compen-
sates for the lack of Runx2. Runx1 is involved in the development
of sternum, occipital bone, and palate by regulating chondrocyte
differentiation [15,16]. However, the impaired development of the
calvariae and clavicles in Runx2+/− mice indicates that Runx1 and
Runx3 cannot compensate for the haplodeﬁciency of Runx2 in their
development. It explains why CCD patients show typical pheno-
types in the calvariae and clavicles [34].
Recently, other groups also reported various Cbfb conditional
knockout mice. Wei’s group generated Cbfb conditional knockout
mice using Prrx1-Cre mice, Sp7-Cre mice, Col1a1-Cre mice, Dermo1-
Cre mice, and Col2a1-Cre mice [35–38]. They also revealed that Cbfb
is required for chondrocyte maturation and osteoblast differentia-
tion and for both intramembranous and endochondral ossiﬁcation.
However, they did not observe the reduction of Runx family pro-
teins in the cartilaginous skeletons of Cbfb Col2a1-Cre mice and
in the calvaria of Cbfbﬂ/ﬂ Sp7-Cre mice and Cbfbﬂ/ﬂ Col1a1-Cre mice
[35,38]. Lim et al. also reported Cbfb conditional knockout mice
using Col1a1-Cre mice [39]. They showed that cortical bone is
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educed in Cbfbﬂ/ﬂ Col1a1-Cre mice with the reduction in the Runx2
rotein, and that Cbfb inhibits polyubiquitination-mediated pro-
eosomal degradation of Runx2. The discrepancy in the stability of
he Runx family proteins in these Cbfb conditional knockout mice
ay have been caused by the difference of the antibodies against
he Runx family proteins used for Western blot analyses.
.  Conclusions
Runx2 plays important roles in the differentiation of cells
f two lineages, osteoblasts and chondrocytes. However, it was
nknown how Runx2 transcription is regulated in osteoblasts
nd chondrocytes. As the 343-bp enhancer is sufﬁcient to induce
steoblast-speciﬁc expression, this enhancer contains elements
ssential to direct Runx2 expression to osteoblasts (Figs. 2 and 3).
unx2 is the most upstream transcription factor for lineage com-
itment from mesenchymal stem cells to osteoblasts. Therefore, it
as also been revealed how mesenchymal stem cells are speciﬁed
o the osteoblast lineage. Furthermore, it has been revealed that
bfb plays important roles in skeletal development by stabilizing
unx family transcription factors (Fig. 3).
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